Editorial Policies

This website is intended to provide the Group's stakeholders, including patients, healthcare professionals, local communities, and employees, with information about major sustainability initiatives implemented by the Group in fiscal 2019. Specific initiatives implemented in accordance with the Company's philosophy are presented in line with management, the environment, and society.
The Sustainability Report 2020 PDF version, which contains the same content as disclosed on this website, can be downloaded from the Sustainability Report archive page.

Explanations of medical and pharmaceutical terms appearing in this report have been provided to foster a wider understanding of the report's content.

Applied Guidelines
  • Global Reporting Initiative (GRI) Sustainability Reporting Standard;
  • Environmental Reporting Guidelines, 2018 version, published by the Ministry of the Environment of Japan
Period covered April 1, 2019, to March 31, 2020
(The report includes examples of activities from April 2020 and thereafter.)
Issue timing August 2020
(Previous report: August 2019; next report: August 2021)
Scope of reporting Mitsubishi Tanabe Pharma and consolidated subsidiaries in Japan and overseas.
(The scope of reporting could differ in accordance with the examples being reported.)
Contact information

Contact Us